Hematologic Cancers Archives - Page 4 of 19 - Together4Cancer Compass

Patients

HCPs

Home

Categories

Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Post category:Hematologic Cancers
Reading time:2 mins read

This study is a cross-sectional analysis of how national health technology assessment (HTA) bodies in major economies ev...

Continue Reading

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Post category:Hematologic Cancers
Reading time:2 mins read

This publication reports a comparative effectiveness analysis of linvoseltamab, a BCMA×CD3 bispecific antibody, versus...

Continue Reading

Treatment of -mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclax.

Post category:Hematologic Cancers
Reading time:1 min read

Study question Can a low‑intensity, once‑weekly “metronomic” regimen of decitabine plus venetoclax provide mea...

Continue Reading

Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab.

Post category:Hematologic Cancers
Reading time:2 mins read

Phase 3 FLAIR trial patients with previously untreated CLL (age 18–75, PS ≤2, no >20% del(17p)) were randomized to i...

Continue Reading

Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Post category:Hematologic Cancers
Reading time:2 mins read

This study evaluated whether the CAR-HEMATOTOX (CAR-HT) score can guide supportive care in multiple myeloma patients rec...

Continue Reading

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Post category:Hematologic Cancers
Reading time:2 mins read

This single-center retrospective study evaluated outcomes of allogeneic stem cell transplantation in 2045 patients with...

Continue Reading